Magnetic resonance imaging for surrogate outcomes and patient selection

Frontiers of Neurology and Neuroscience

Volumn 25, Issue , 2009, Pages 189-192

  Hsia, Amie W ^a   Kidwell, Chelsea S ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b WHC Stroke Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; DESMOTEPLASE; GADOLINIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

BRAIN ATROPHY; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEMENTIA; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MARKER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; MACROPHAGE; MECHANICAL THROMBECTOMY; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SELECTION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; STROKE; TREATMENT RESPONSE; WHITE MATTER; ARTICLE; METHODOLOGY;

CLINICAL TRIALS AS TOPIC; HUMANS; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES; PATIENT SELECTION;

EID: 67649779941     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000209499     Document Type: Short Survey

References (7)

1. Chertkow H, Black S: Imaging biomarkers and their role in dementia clinical trials. The Can J Neurol Sci 2007;34:77-83.
2. Miller DH: Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004;1:284-294.
3. Lovblad KO, Baird AE, Schlaug G, et al: Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997;42:164-170.
4. Tong DC, Yenari MA, Albers GW, M OB, Marks M P, Moseley ME: Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 h) ischemic stroke. Neurology 1998;50:864-870.
5. Barber PA, Parsons M W, Desmond PM, et al: The use of PWI and DWI measures in the design of 'proof-of-concept' stroke trials. J Neuroimaging 2004;14:123-132.
6. Hacke W, Albers G, Al-Rawi Y, et al: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-h window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
7. Albers GW, Thijs VN, Wechsler L, et al: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.